The incidence rate of head and neck squamous cell carcinoma (HNSCC) has steadily increased over the past decade. However, treatment options for metastatic HNSCC are often limited and the 5-year survival rate has remained static. Therefore, the development and assessment of more efficient but less toxic therapeutic strategies is an unmet need for treatment of more extensive HNSCC. Here, we report that CYT997, a novel microtubule-disrupting agent, exerts strong activity in inhibiting HNSCC cell invasion and metastasis. The loss of invasion capacity by CYT997 was accompanied by an associated increase in cell adhesion and the reversal of epithelial-mesenchymal transition (EMT). Increased expression of E-cadherin protein and decreased expression of Vimentin protein became evident in HNSCC cells following CYT997 exposure, which were consistently observed in HNSCC xenografts from the mice receiving CYT997. Moreover, the capacity of invasive HNSCC cells to form pulmonary metastases was significantly blocked with CYT997 treatment, indicating that the diminishment of EMT traits contributes to CYT997-suppressed metastasis.
strategies against HNSCC metastasis. Generally, patients with early stage HNSCC, particularly those limited to the site of origin, are treated with either surgery or radiation therapy. If patients have more extensive cancers, they often receive chemotherapy. However, treatment options for recurrent and metastatic HNSCC are often limited, with palliative treatment generally offered in these situations. Therefore, the development and assessment of a new chemotherapy, which holds great potential for higher efficacy and lesser side effects, are imperative for the management of HNSCC, especially for metastatic tumours.
Microtubules are filamentous intracellular structures that are responsible for the maintenance of cell shape and the facilitation of cell motility. 3 Targeting microtubules to disrupt their normal function within the cancer cell has proven to be one of the best classes of cancer chemotherapeutic drugs available in clinics to date. 4 The microtubule-targeting agents (MTAs), including Paclitaxel and Docetaxel, are very effective cancer drugs with therapeutic benefits in both hematopoietic and solid tumours. These drugs, as "stabilizers" or "destabilizers" of microtubules, potently suppress the dynamic stability of the microtubules to block mitotic progression and trigger apoptosis. 4, 5 However, there is little evidence how MTAs affect cell motility, especially in the process of cancer cell invasion and metastasis.
CYT997, a new microtubule-disrupting agent inhibiting tubulin polymerization and disrupting cellular microtubules, has been used as an anticancer chemo drug for a wide range of cancer types. [6] [7] [8] The oral activity of CYT997 is more effective than most other MTAs.
Phase I clinical trials have assessed the anticancer efficacy and safety of CYT997 in patients with solid tumours, and Phase II clinical trials are performing studies for the treatment of selected tumors. 8, 9 We have found that CYT997 can trigger oxidative stress-associated apoptosis and mTOR-dependent autophagy in HNSCC cells, and CYT997-induced autophagy appears to have a protective role against apoptosis by inhibiting the induction of excessively high reactive oxygen species (ROS). 10 A superior inhibitory effect of CYT997 on prostate tumour growth and metastasis was demonstrated in our previous work, suggesting that CYT997 may also regulate the potential of invasion and metastasis of HNSCC cells.
Here, we study the anticancer activity of CYT997 in cell invasion and metastasis using cultured HNSCC cell lines and in vivo animal models. We show that CYT997 suppresses invasion and metastasis of HNSCC cells by increasing cell adhesion and reversing epithelialmesenchymal transition (EMT), which largely depends on the reduction in intracellular levels of ATP production. By testing the effects of the addition of ATP on CYT997-induced suppression of invasion, we provide evidence that intracellular reduction in ATP levels has an important role in limiting HNSCC cell invasion/metastasis under the influence of CYT997.
| MATERIALS AND METHODS

| Cell lines and culture conditions
Invasive HN6 and HN12 cells derived from HNSCCs have been previously described. 11, 12 All cells were maintained in Dulbecco's modified Eagle's medium containing 10% foetal bovine serum at 37°C in a humidified incubator supplied with 5% CO 2 . 
| Animal studies
All animal experiments were approved by the Institutional Animal 
| Statistical analysis
Statistical analyses were performed by unpaired Student's t test for two group comparisons and ANOVA for multigroup comparisons at a significance level of P < 0.05. Where indicated, the results were representative of at least three independent experiments performed in triplicate and were expressed as the mean ± SD.
3 | RESULTS
| CYT997 suppresses migration and invasion in HNSCC cells
Our previous study has shown that CYT997 can inhibit cell viability and induce oxidative stress-associated apoptosis in HNSCC cells. 10 These data prompted us to investigate whether CYT997 has other anticancer potential in HNSCC cells. To mitigate the inhibitory effect on cell viability, we used 20 nmol/L CYT997 in the following in vitro studies, which was much lower than IC50
of 100 nmol/L in HNSCC cells. HN6 and HN12 are two highly invasive HNSCC cell lines, and no significant growth rate and cell death was noted in these cells, in the presence or absence of 20 nmol/L CYT997 (data not shown). However, CYT997 treatment led to a clear reduction in wound-healing capability ( Figure 1A ).
Matrigel invasion assays further showed reduced invasion potential in HN6 and HN12 cells following exposure of CYT997 ( Figure 1B ).
To determine the contribution of EMT in CYT997-induced suppression of cell invasion, we assessed the morphological changes of cells with or without CYT997 treatment. Long-term treatment (3 days) of HN6 and HN12 cells with CYT997 reversed EMT as evidenced by converting from an elongated mesenchymal shape into a "cuboidal" epithelial structure ( Figure 1C ). Moreover, 3D tumour spheroid invasion followed over a period of 4 days as shown in Figure 1D revealed that invasion from HN6-and HN12-derived spheroids was much less pronounced in CYT997 treatment compared with the control groups treated with DMSO.
| CYT997 inhibits HNSCC cell EMT
To understand the mechanism underpinning CYT997-induced suppression of invasion, we sought to determine the molecules mostly Most of the ATP in cells is produced by ATP synthase in mitochondria, and IF1 is a natural inhibitor protein of mitochondrial ATP synthase. 18 Given the fact that CTY997 induced repression 
| Restoration of ATP attenuates CYT997-induced suppression of invasion in HNSCC cells
The maintenance of an adequate ATP supply is of crucial importance for the mechanisms of structural remodelling in cells with high shape plasticity. 19 Therefore, we determined whether the loss of ATP played an essential role in CYT997-induced suppression of cells invasion. CYT997 treatment alone appeared no effect on via- Oral drug administration is the most convenient method of medication and now more than 60% of marketed drugs are used as oral products. CYT997 can be well absorbed after oral administration, with mean Tmax and T1/2 of 1.1 and 3.2 hours, respectively. 9 In our previous animal study, tumour-bearing mice treated with CYT997 by oral gavage showed significantly smaller xenografts compared with control mice. 10 We have not successfully identified metastatic HNSCC cells in the lungs of mice in the previous study, which may be due to the termination of the animal experiment too early. In this study, we inoculated a low number of HN12 cells As the "principal energy currency," ATP is involved in metabolism and most of the other cellular activities. 19 However, the role of intracellular ATP in sustaining cell motility is very obscure, which may depend on its levels and distribution pattern. Mitochondria is the site of ATP generation, and the dysfunction of mitochondria in HNSCC cells has been found in the presence of CYT997, which may explain how the cellular levels of ATP production were impaired.
Tumour microenvironment is ATP rich, suggesting a role for puriner- 
